Seaport Therapeutics develops innovative neuropsychiatric medicines using its proprietary Glyph technology platform, which enhances oral bioavailability and minimizes side effects. Targeting areas with significant unmet patient needs, the company leverages clinically validated mechanisms to advance a pipeline of unique therapeutics. Guided by a seasoned team of experts and a strong network of scientists and clinicians, Seaport is positioned to make a meaningful impact in mental health treatment.
No jobs found. Subscribe below to get notified when we find something for you.
Searching